Taken together, these results confirm dual PI3K/mTOR pathway blockade by BEZ235, as evidenced by diminished cyclin D1 and cyclin D3, resulting in G0/G1 growth arrest in NSCLC cells, regardless of EGFR status. This evidence concerns the gene EGFR and non-small cell lung carcinoma.